by Fred Pennic 07/14/2023 Leave a Comment
Versanis logo
What You Should Know:
Eli Lilly announced an agreement to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of…
Continue Reading
By Mark Melchionna
July 11, 2023 – New research indicated that treating the musculoskeletal health of patients with neck and low back pain did not benefit significantly from an individually tailored artificial intelligence (AI)-based application.
The World…
Continue Reading
What You Should Know:
Sonio, a French medtech specializing in pregnant people and children’s health raises $14M following the initial commitment of the EIC Fund (European Innovation Council) last December. This round is led by Cross Border…
Continue Reading
With laws such as the “No Surprises Act,” government has thrown its considerable weight behind the pressure on payers and clinicians to give patients good-faith estimates of the total cost of treatment. According to…
Continue Reading
By Hannah Nelson
July 05, 2023 – Standards-development organization Health Level Seven International (HL7) and The World Health Organization (WHO) have signed a Project Collaboration Agreement to support the global adoption of open interoperability standards.
Adopting interoperability…
Telehealth is here to stay, and the Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act has been reintroduced in the US Senate, this time by a bipartisan group of…
Continue Reading
Advantus Health Partners forms a new 10-year, $2.9B strategic partnership with Medline to establish agility and scale, supply chain resiliency and enhanced clinical integration with the nurses and physicians who use Medline’s product. This…
Continue Reading
Advantus Health Partners forms a new 10-year, $2.9B strategic partnership with Medline to establish agility and scale, supply chain resiliency and enhanced clinical integration with the nurses and physicians who use Medline’s product. This…
Continue Reading
Mark Cuban Cost Plus Drug Company (MCCPDC) has announced a partnership with male fertility and sexual healthcare company Posterity Health to provide males access to medications to treat infertility, sexual dysfunction and low testosterone. Posterity…
Continue Reading
Virtual primary care company LifeMD is jumping on the glucagon-like peptide 1 (GLP-1) train through its launch of a weight management program, the company announced Tuesday.
New York City-based LifeMD is a direct-to-consumer company and…
